To hear about similar clinical trials, please enter your email below
Trial Title:
Retrospective Register for Uveal Melanoma
NCT ID:
NCT05733728
Condition:
Uveal Melanoma
Conditions: Official terms:
Melanoma
Uveal Neoplasms
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Other
Intervention:
Intervention type:
Other
Intervention name:
any therapy suitable
Description:
any therapy suitable
Arm group label:
Uveal Melanoma
Summary:
Background: Uveal melanoma (UM) is a common primary ocular malignancy associated with
limited overall survival in the advanced stage of the disease. Fundamental breakthrough
regarding the management of the disease and the overall-survival have not yet been
achieved. Studies with large cohorts are difficult to perform due to limited patient
numbers, therefore retrospective analyses are of great potential to gain further
knowledge in a disease with high clinical needs.
Aim: The proposed project is a register for patients with UM treated at the Department of
Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and
31.12.2021.
Patients and Methods: Patients treated for UM at the Department of Ophthalmology and
Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021 will be
included in the register. Information on the baseline characteristics, survival times and
course of the disease will be gathered via retrospective chart review and saved in a
password-secured database.
Criteria for eligibility:
Study pop:
Patients with uveal melanoma
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria
- Patients 18 - 99 years
- Diagnosis of uveal melanoma Exclusion Criteria
- Patients younger than 18 years of age
- Inadequate or missing information on the clinical course in patient charts
Gender:
All
Minimum age:
18 Years
Maximum age:
99 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Medical University of Vienna
Address:
City:
Vienna
Zip:
1090
Country:
Austria
Status:
Recruiting
Contact:
Last name:
Reinhard Told, MD, PhD
Phone:
+43140400
Phone ext:
48470
Start date:
January 23, 2023
Completion date:
December 31, 2030
Lead sponsor:
Agency:
Medical University of Vienna
Agency class:
Other
Source:
Medical University of Vienna
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05733728
